Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
After finishing at $4.63 in the prior trading day, Arcadia Biosciences Inc (NASDAQ: RKDA) closed at $4.65, up 0.43%. In other words, the price has increased by $0.43 from its previous closing price. On the day, 79150.0 shares were traded. RKDA stock price reached its highest trading level at $5.19 during the session, while it also had its lowest trading level at $4.46.
Ratios:
Our goal is to gain a better understanding of RKDA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.41 and its Current Ratio is at 3.99. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 17, 2020, Reiterated its Buy rating but revised its target price to $12 from $14 previously.
On June 09, 2015, Piper Jaffray started tracking the stock assigning a Overweight rating and target price of $10.Piper Jaffray initiated its Overweight rating on June 09, 2015, with a $10 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 03 ’25 when Kawakami Mark bought 700 shares for $2.49 per share. The transaction valued at 1,743 led to the insider holds 2,681 shares of the business.
Schaefer Thomas J. bought 700 shares of RKDA for $1,743 on Feb 03 ’25. The Chief Executive Officer now owns 2,819 shares after completing the transaction at $2.49 per share. On Aug 01 ’24, another insider, Kawakami Mark, who serves as the Chief Financial Officer of the company, bought 700 shares for $2.06 each. As a result, the insider paid 1,442 and bolstered with 1,981 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RKDA now has a Market Capitalization of 6356736 and an Enterprise Value of 2750935. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.21 while its Price-to-Book (P/B) ratio in mrq is 0.71. Its current Enterprise Value per Revenue stands at 0.523 whereas that against EBITDA is -0.39.
Stock Price History:
The Beta on a monthly basis for RKDA is 0.50, which has changed by 0.54024506 over the last 52 weeks, in comparison to a change of 0.12792087 over the same period for the S&P500. Over the past 52 weeks, RKDA has reached a high of $10.31, while it has fallen to a 52-week low of $2.40. The 50-Day Moving Average of the stock is 8.24%, while the 200-Day Moving Average is calculated to be 14.39%.
Shares Statistics:
The stock has traded on average 15.19K shares per day over the past 3-months and 30100 shares per day over the last 10 days, according to various share statistics. A total of 1.37M shares are outstanding, with a floating share count of 1.36M. Insiders hold about 0.82% of the company’s shares, while institutions hold 5.60% stake in the company. Shares short for RKDA as of 1749772800 were 22249 with a Short Ratio of 1.46, compared to 1747267200 on 19344. Therefore, it implies a Short% of Shares Outstanding of 22249 and a Short% of Float of 1.6400000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
